z-logo
open-access-imgOpen Access
Neuroendovascular Cerebral Sinus Stenting in Idiopathic Intracranial Hypertension
Author(s) -
Fawaz AlMufti,
Vincent Dodson,
Krishna Amuluru,
Jessy Walia,
Ethan Wajswol,
Rolla Nuoman,
Irwin A. Keller,
Steven Schonfeld,
Sudipta Roychowdhury,
Gaurav Gupta
Publication year - 2019
Publication title -
interventional neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.07
H-Index - 5
eISSN - 1664-9737
pISSN - 1664-5545
DOI - 10.1159/000500051
Subject(s) - medicine , papilledema , stent , surgery , stenosis , tinnitus , sinus (botany) , pathophysiology , radiology , botany , psychiatry , biology , genus
Idiopathic intracranial hypertension (IIH) is a rare, ill-understood disease of significant morbidity. Because the pathophysiology is poorly understood, treatment protocols are not uniform and are directed towards alleviating the most common symptoms: headache and visual loss. In this review, we analyze 25 case series, all of which included IIH patients ( n = 408) who were treated with placement of a venous sinus stent. Among 342 patients who had headache, 240 patients (70.2%) had improvement or resolution of headache after the stent insertion. Of the 217 patients documented to have visual problems, visual acuity was improved or stabilized in 161 patients (74.2%). Of the 304 patients with papilledema, 257 showed resolution or improved (84.5%). Of the 124 patients who presented with pulsatile tinnitus, it was resolved in 110 patients (88.7%) after stent placement. Endovascular management of dural sinus stenosis is therefore clinically efficacious in patients with IIH who have failed medical and surgical therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom